Neoadjuvant versus adjuvant systemic therapy for operable breast cancer: Equivalent outcomes?

Annals of Surgery

Volumn 257, Issue 2, 2013, Pages 180-181

  Smith, Barbara L ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; TUMOR MARKER;

BREAST CANCER; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; DISEASE FREE SURVIVAL; ECHOGRAPHY; EDITORIAL; HUMAN; INTRADUCTAL CARCINOMA; MAMMOGRAPHY; OVERALL SURVIVAL; PARTIAL MASTECTOMY; POSTOPERATIVE CARE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RECURRENCE RISK; SYSTEMIC THERAPY; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR VOLUME;

BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; TREATMENT OUTCOME;

EID: 84872349027     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e318280a688     Document Type: Editorial

References (7)

1. Buchholz TA, Lehman CD, Harris JR, et al. Statement of the science concerning loco-regional treatments after preoperative chemotherapy for breast cancer: a National Cancer Institute Conference. J Clin Oncol. 2008;26:791-797.
2. Rastogi P, Anderson SJ, Bear HD, et al. Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27. J Clin Oncol. 2008;26:778-785.
3. van der Hage JA, Cornelis JH, van de Velde CJ, et al. Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer Trial 10902. J Clin Oncol. 2001;19:4224-4237.
4. Wolmark N, Wang J, Mamounas E, et al. Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18. Cancer. 2001;30:96-102.
5. Fisher B, Brown A, Mamounas E, et al. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol. 1997;15:2483-2493.
6. Mittendorf E, Buchholz TA, Tucker SL, et al. Impact of chemotherapy sequence on local-regional failure risk in breast cancer patients undergoing breast-conserving therapy. Ann Surg. 2013;257:173-179.
7. Chen AM, Meric-Bernstam F, Hunt KK, et al. Breast-conserving therapy after neoadjuvant chemotherapy: the M. D. Anderson Cancer Center experience. J Clin Oncol. 2004;22:2303-2312.